Go Pro
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

OrthoPediatrics logo
$20.88 +0.01 (+0.05%)
Closing price 04:00 PM Eastern
Extended Trading
$20.88 +0.01 (+0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About OrthoPediatrics Stock (NASDAQ:KIDS)

Advanced

Key Stats

Today's Range
$20.70
$21.17
50-Day Range
$16.65
$20.88
52-Week Range
$14.42
$22.80
Volume
268,888 shs
Average Volume
155,062 shs
Market Capitalization
$536.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.78
Consensus Rating
Moderate Buy

Company Overview

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis. OrthoPediatrics also offers unique epiphysiodesis and guided growth devices designed to correct limb length discrepancies and angular deformities in growing children. These devices are supported by accompanying instrumentation that simplifies surgical technique and enhances procedural efficiency.

OrthoPediatrics markets its products through a direct sales organization in the United States and through distributors and regional offices in Europe, Latin America and the Asia-Pacific region. The company collaborates with leading pediatric orthopedic surgeons and academic institutions to advance clinical research, refine surgical protocols and expand its product offerings. Continuous investment in R&D underpins its strategy to fill gaps in pediatric care that are often overlooked by general orthopedic manufacturers.

Led by a management team with deep expertise in the orthopedic device industry, OrthoPediatrics emphasizes quality systems, regulatory compliance and physician education. The company’s global footprint and specialized focus on the pediatric segment position it as a growing participant in the niche market of children’s orthopedics, striving to improve clinical outcomes and quality of life for young patients worldwide.

AI Generated. May Contain Errors.

OrthoPediatrics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

KIDS MarketRank™: 

OrthoPediatrics scored higher than 50% of companies evaluated by MarketBeat, and ranked 511th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    OrthoPediatrics has a consensus price target of $24.78, representing about 18.7% upside from its current price of $20.88.

  • Amount of Analyst Coverage

    OrthoPediatrics has only been the subject of 3 research reports in the past 90 days.

  • Read more about OrthoPediatrics' stock forecast and price target.
  • Earnings Growth

    Earnings for OrthoPediatrics are expected to grow in the coming year, from ($1.13) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OrthoPediatrics is -12.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OrthoPediatrics is -12.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    OrthoPediatrics has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about OrthoPediatrics' valuation and earnings.
  • Percentage of Shares Shorted

    5.10% of the float of OrthoPediatrics has been sold short.
  • Short Interest Ratio / Days to Cover

    OrthoPediatrics has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in OrthoPediatrics has recently decreased by 1.59%, indicating that investor sentiment is improving.
  • Dividend Yield

    OrthoPediatrics does not currently pay a dividend.

  • Dividend Growth

    OrthoPediatrics does not have a long track record of dividend growth.

  • News Sentiment

    OrthoPediatrics has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added OrthoPediatrics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OrthoPediatrics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.50% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OrthoPediatrics' insider trading history.
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KIDS Stock News Headlines

Russia and China are about to lose their leverage
Russia, China, and Indonesia control nearly 80 percent of the world's nickel supply, producing 316 times more than the United States. One small American company operates the only primary nickel mine capable of closing that gap. Washington has already invested over $137 million, and Tesla has signed a six-year supply deal. Analysts believe a direct government investment could be next, and insiders are already positioning ahead of any announcement.tc pixel
See More Headlines

KIDS Stock Analysis - Frequently Asked Questions

OrthoPediatrics' stock was trading at $17.76 at the start of the year. Since then, KIDS stock has increased by 17.6% and is now trading at $20.88.

OrthoPediatrics Corp. (NASDAQ:KIDS) issued its earnings results on Tuesday, August, 4th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.04. The company earned $70.51 million during the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 7.01% and a negative net margin of 16.31%.
Read the conference call transcript
.

OrthoPediatrics (KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

OrthoPediatrics' top institutional investors include Wasatch Advisors LP (2.01%). Insiders that own company stock include David R Bailey, Fred Hite, Joseph W Hauser, Gregory A Odle, Daniel J Gerritzen, Mark C Throdahl and Terry D Schlotterback.
View institutional ownership trends
.

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Today
8/04/2026
Last Earnings
8/04/2026
Next Earnings (Estimated)
8/04/2026
Canaccord Genuity's 46th Annual Growth Conference
8/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:KIDS
CIK
1425450
Employees
200
Year Founded
2006

Price Target and Rating

High Price Target
$34.00
Low Price Target
$20.00
Potential Upside/Downside
+18.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.65 million
Net Margins
-16.31%
Pretax Margin
-16.27%
Return on Equity
-7.01%
Return on Assets
-4.86%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
5.21
Quick Ratio
2.37

Sales & Book Value

Annual Sales
$236.35 million
Price / Sales
2.27
Cash Flow
$0.17 per share
Price / Cash Flow
125.51
Book Value
$13.82 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
25,680,000
Free Float
17,337,000
Market Cap
$536.20 million
Optionable
Optionable
Beta
0.98

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:KIDS) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners